Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease
Open Access
- 13 November 2007
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (46) , 18259-18264
- https://doi.org/10.1073/pnas.0705501104
Abstract
We created transgenic mice that overexpress WT androgen receptor (AR) exclusively in their skeletal muscle fibers. Unexpectedly, these mice display androgen-dependent muscle weakness and early death, show changes in muscle morphology and gene expression consistent with neurogenic atrophy, and exhibit a loss of motor axons. These features reproduce those seen in models of Kennedy disease, a polyglutamine expansion disorder caused by a CAG repeat expansion in the AR gene. These findings demonstrate that toxicity in skeletal muscles is sufficient to cause motoneuron disease and indicate that overexpression of the WT AR can exert toxicity comparable with the polyglutamine expanded protein. This model has two clear implications for Kennedy disease: (i) mechanisms affecting AR gene expression may cause neuromuscular symptoms similar to those of Kennedy disease and (ii) therapeutic approaches targeting skeletal muscle may provide effective treatments for this disease.Keywords
This publication has 37 references indexed in Scilit:
- Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in modelJournal of Clinical Investigation, 2006
- Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in modelJournal of Clinical Investigation, 2006
- Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscleThe FASEB Journal, 2006
- Anabolic responsiveness of skeletal muscles correlates with androgen receptor protein but not mRNACanadian Journal of Physiology and Pharmacology, 2006
- The AXH Domain of Ataxin-1 Mediates Neurodegeneration through Its Interaction with Gfi-1/Senseless ProteinsCell, 2005
- Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutationEuropean Journal of Neuroscience, 2004
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Testosterone Reduction Prevents Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular AtrophyNeuron, 2002